[Role of prostaglandin E2 in bone].
Oida
Hiroji
H
Fukui Research Laboratories, Ono Pharmaceutical Co. Ltd.
Oda
Kazunori
K
Maruyama
Takayuki
T
D000818:Animals; D016723:Bone Remodeling / Q000235:genetics / Q000502:physiology; D001862:Bone Resorption / Q000235:genetics; D015232:Dinoprostone / Q000502:physiology*; D004195:Disease Models, Animal; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism; D010012:Osteogenesis / Q000235:genetics / Q000502:physiology; D010024:Osteoporosis / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D018078:Receptors, Prostaglandin E / Q000819:agonists* / Q000502:physiology; D058309:Receptors, Prostaglandin E, EP4 Subtype; D014157:Transcription Factors / Q000378:metabolism
D009363:Neoplasm Proteins; C545650:PTGER4 protein, human; D018078:Receptors, Prostaglandin E; D058309:Receptors, Prostaglandin E, EP4 Subtype; D014157:Transcription Factors; D015232:Dinoprostone